Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A PolyPid Ltd. Filed by: Aurum Ventures M.K.I. Ltd.

May 4, 2026 6:13 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Number of shares beneficially owned as shown in Rows 5, 7 and 9 consists of 3,550,133 outstanding Ordinary Shares plus 1,451,428 Ordinary Shares issuable under currently exercisable warrants. As described in Item 4, the Ordinary Shares reported in Rows 5, 7 and 9, and the percentage shown in Row 11, reflect the number of Ordinary Shares that would be issuable upon full exercise of all such warrants beneficially owned by the Reporting Person (as all are currently exercisable) and do not give effect to "blocker" clauses in the warrants that limit exercise of warrants to the extent it would result in beneficial ownership above 9.9% at any given time. If giving effect to such blockers, the actual number of Ordinary Shares that may be held by the Reporting Person at one time is less than the number of shares reported in Rows 5, 7 and 9, and the percentage ownership is less than that shown in Row 11.


SCHEDULE 13G



Aurum Ventures M.K.I. Ltd.
Signature:/s/ Nir Dror-Darwish
Name/Title:Nir Dror-Darwish/Authorized Signatory
Date:05/04/2026
Signature:/s/ Ilan Lior
Name/Title:Ilan Lior/Authorized Signatory
Date:05/04/2026

Categories

SEC Filings